Determination of Antibiotic Hypersensitivity among 4,000 Single-Gene-Knockout Mutants of Escherichia coli

ABSTRACT We have tested the entire Keio collection of close to 4,000 single-gene knockouts in Escherichia coli for increased susceptibility to one of seven different antibiotics (ciprofloxacin, rifampin, vancomycin, ampicillin, sulfamethoxazole, gentamicin, or metronidazole). We used high-throughput screening of several subinhibitory concentrations of each antibiotic and reduced more than 65,000 data points to a set of 140 strains that display significantly increased sensitivities to at least one of the antibiotics, determining the MIC in each case. These data provide targets for the design of “codrugs” that can potentiate existing antibiotics. We have made a number of double mutants with greatly increased sensitivity to ciprofloxacin, and these overcome the resistance generated by certain gyrA mutations. Many of the gene knockouts in E. coli are hypersensitive to more than one antibiotic. Together, all of these data allow us to outline the cell's “intrinsic resistome,” which provides innate resistance to antibiotics.

[1]  S. McLeod,et al.  Mechanism of chromosome compaction and looping by the Escherichia coli nucleoid protein Fis. , 2006, Journal of molecular biology.

[2]  Jonathan A. Mills,et al.  An array of target-specific screening strains for antibacterial discovery , 2002, Nature Biotechnology.

[3]  K. Drlica,et al.  DNA gyrase, topoisomerase IV, and the 4-quinolones , 1997, Microbiology and molecular biology reviews : MMBR.

[4]  Maria J. Gomez,et al.  Genes Involved in Intrinsic Antibiotic Resistance of Acinetobacter baylyi , 2006, Antimicrobial Agents and Chemotherapy.

[5]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Silhavy,et al.  Probing the barrier function of the outer membrane with chemical conditionality. , 2006, ACS chemical biology.

[7]  Maria Paola Costi,et al.  Antibacterial agent discovery using thymidylate synthase biolibrary screening. , 2006, Journal of medicinal chemistry.

[8]  Angela Lee,et al.  Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa: Novel Agents for Combination Therapy , 2001, Antimicrobial Agents and Chemotherapy.

[9]  R. Hancock.  The complexities of antibiotic action , 2007, Molecular systems biology.

[10]  B. Stockwell,et al.  Multicomponent therapeutics for networked systems , 2005, Nature Reviews Drug Discovery.

[11]  P. Heisig,et al.  Impact of gyrA and parCMutations on Quinolone Resistance, Doubling Time, and Supercoiling Degree of Escherichia coli , 1999, Antimicrobial Agents and Chemotherapy.

[12]  J. Andrews,et al.  Determination of minimum inhibitory concentrations. , 2001, The Journal of antimicrobial chemotherapy.

[13]  G. Mendz,et al.  Oxidases and reductases are involved in metronidazole sensitivity in Helicobacter pylori. , 2001, The international journal of biochemistry & cell biology.

[14]  Robert Hermann,et al.  Methods for Intense Aeration, Growth, Storage, and Replication of Bacterial Strains in Microtiter Plates , 2000, Applied and Environmental Microbiology.

[15]  B. Wanner,et al.  Conditional-Replication, Integration, Excision, and Retrieval Plasmid-Host Systems for Gene Structure-Function Studies of Bacteria , 2001, Journal of bacteriology.

[16]  Robert P. St.Onge,et al.  The Chemical Genomic Portrait of Yeast: Uncovering a Phenotype for All Genes , 2008, Science.

[17]  J. Collins,et al.  A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics , 2007, Cell.

[18]  Melanie B. Berkmen,et al.  DksA potentiates direct activation of amino acid promoters by ppGpp , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  V. Marquez,et al.  Inhibition of cytidine deaminase by 2-oxopyrimidine riboside and related compounds. , 1980, Biochemical pharmacology.

[20]  W. Hill,et al.  Survival of recombination-deficient mutants of Escherichia coli during incubation with nalidixic acid , 1978, Journal of bacteriology.

[21]  T. Lundqvist,et al.  Exploitation of structural and regulatory diversity in glutamate racemases , 2007, Nature.

[22]  Jeffrey H. Miller,et al.  Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. , 2003, DNA repair.

[23]  A. van der Kuy,et al.  [The penicillins]. , 1974, Tijdschrift voor ziekenverpleging.

[24]  Grace Yim,et al.  Antibiotics as signalling molecules , 2007, Philosophical Transactions of the Royal Society B: Biological Sciences.

[25]  A. Segall,et al.  DNA repair, a novel antibacterial target: Holliday junction‐trapping peptides induce DNA damage and chromosome segregation defects , 2006, Molecular microbiology.

[26]  H. Mori,et al.  Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection , 2006, Molecular systems biology.

[27]  R. Mei,et al.  Killing by Ampicillin and Ofloxacin Induces Overlapping Changes in Escherichia coli Transcription Profile , 2004, Antimicrobial Agents and Chemotherapy.

[28]  S. Loewe.  The problem of synergism and antagonism of combined drugs. , 1953, Arzneimittel-Forschung.

[29]  D. Court,et al.  An efficient recombination system for chromosome engineering in Escherichia coli. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Jeffrey H. Miller.  A Short Course in Bacterial Genetics: A Laboratory Manual and Handbook for Escherichia coli and Rela , 1992 .

[31]  S. Garges.  A Short Course in Bacterial Genetics. A Laboratory Manual and Handbook for Escherichia coli and Related Bacteria. By Jeffrey H. Miller. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1992. , 1993 .

[32]  Jean M. Severin,et al.  Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimization. , 2004, Journal of medicinal chemistry.

[33]  Roy Kishony,et al.  Networks from drug–drug surfaces , 2007, Molecular systems biology.

[34]  T. Ideker,et al.  Supporting Online Material for A Systems Approach to Mapping DNA Damage Response Pathways , 2006 .

[35]  T. Silhavy,et al.  Periplasmic Peptidyl Prolyl cis-trans Isomerases Are Not Essential for Viability, but SurA Is Required for Pilus Biogenesis in Escherichia coli , 2005, Journal of bacteriology.

[36]  J. McClure,et al.  Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  L. Amzel,et al.  Structure and function of the E. coli dihydroneopterin triphosphate pyrophosphatase: a Nudix enzyme involved in folate biosynthesis. , 2007, Structure.

[38]  K. Lewis,et al.  Bacteria lacking a multidrug pump: a sensitive tool for drug discovery. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Gross,et al.  SurA, a periplasmic protein with peptidyl-prolyl isomerase activity, participates in the assembly of outer membrane porins. , 1996, Genes & development.

[40]  J. Davies.  Microbes have the last word , 2007, EMBO reports.

[41]  H. Nikaido.  Outer membrane barrier as a mechanism of antimicrobial resistance , 1989, Antimicrobial Agents and Chemotherapy.

[42]  S. Levy,et al.  Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.

[43]  J. Musser,et al.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights , 1995, Clinical microbiology reviews.

[44]  S. Altuvia,et al.  DeoT, a DeoR-type transcriptional regulator of multiple target genes. , 2006, FEMS microbiology letters.

[45]  A. J. Wright.  Symposium on Antimicrobial Agents—Part VIThe Penicillins , 1999 .

[46]  R. G. Lloyd,et al.  RecN protein and transcription factor DksA combine to promote faithful recombinational repair of DNA double‐strand breaks , 2005, Molecular microbiology.

[47]  I. Simon,et al.  Reconstructing dynamic regulatory maps , 2007, Molecular systems biology.

[48]  S. Levy,et al.  Molecular Mechanisms of Antibacterial Multidrug Resistance , 2007, Cell.

[49]  A. Segall,et al.  Holliday junction-binding peptides inhibit distinct junction-processing enzymes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Bonnie L. Bassler,et al.  The major Vibrio cholerae autoinducer and its role in virulence factor production , 2007, Nature.

[51]  S. Levy,et al.  Reversal of Tetracycline Resistance Mediated by Different Bacterial Tetracycline Resistance Determinants by an Inhibitor of the Tet(B) Antiport Protein , 1999, Antimicrobial Agents and Chemotherapy.

[52]  Jo Handelsman,et al.  Biotechnological prospects from metagenomics. , 2003, Current opinion in biotechnology.

[53]  C. Rock,et al.  Prediction of Mechanisms of Action of Antibacterial Compounds by Gene Expression Profiling , 2004, Antimicrobial Agents and Chemotherapy.

[54]  S. Levy,et al.  Novel anti-infection agents: small-molecule inhibitors of bacterial transcription factors. , 2007, Bioorganic & medicinal chemistry letters.

[55]  Jacques Neefjes,et al.  Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1 , 2007, Nature.

[56]  J. Buynak.  Understanding the longevity of the β-lactam antibiotics and of antibiotic/β-lactamase inhibitor combinations , 2006 .

[57]  J. W. Chase,et al.  Escherichia coli exonuclease VII. Cloning and sequencing of the gene encoding the large subunit (xseA). , 1986, The Journal of biological chemistry.

[58]  Jeffrey H. Miller,et al.  Mutagenicity of the cytidine analog zebularine in Escherichia coli. , 2004, DNA repair.

[59]  Daniel Kahne,et al.  Lipoprotein SmpA is a component of the YaeT complex that assembles outer membrane proteins in Escherichia coli , 2007, Proceedings of the National Academy of Sciences.

[60]  Xuejun Liu,et al.  Comparison of the Changes in Global Gene Expression of Escherichia coli Induced by Four Bactericidal Agents , 2003, Journal of Molecular Microbiology and Biotechnology.

[61]  J. Miller,et al.  Proliferation of mutators in A cell population , 1997, Journal of bacteriology.

[62]  R. Kishony,et al.  Functional classification of drugs by properties of their pairwise interactions , 2006, Nature Genetics.

[63]  J. Plowman,et al.  Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues. , 1991, Journal of medicinal chemistry.

[64]  J. Davies,et al.  Transcription Modulation of Salmonella enterica Serovar Typhimurium Promoters by Sub-MIC Levels of Rifampin , 2006, Journal of bacteriology.

[65]  Michelle D. Brazas,et al.  Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance. , 2005, Drug discovery today.